Comparing blood pressure drugs after heart stent placement
Treatments studied
Part of Heart & circulation clinical trials.
This trial compares two different combinations of blood pressure medicines to see which works better for people who have had a heart stent placed. It may help find the best treatment plan for controlling blood pressure after the procedure.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 50 and 70 years old.
- You have high blood pressure and coronary artery disease (narrowed heart arteries).
- You are currently in the hospital to have a planned heart stent placed.
- You need to take two blood pressure medicines together.
- You are already taking a beta-blocker, a cholesterol-lowering medicine, and a blood thinner (antiplatelet).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether a combination of two blood pressure drugs (sacubitril/valsartan) is better than one drug alone (valsartan) at improving heart function in people with high blood pressure. It may help reduce strain on the heart's upper chambers.
This study tests whether giving a drug called nicorandil directly into the heart artery just before placing a stent can help keep blood flow normal and reduce complications after the procedure.
This trial compares two ways of guiding cholesterol-lowering treatment in people who have had a heart stent placed. It aims to find which method helps lower heart risks more effectively.
This study compares two ways to open blocked heart arteries: one uses a balloon coated with medicine, and the other uses a small mesh tube (stent) that releases medicine. The goal is to see which works better for people with chest pain or a recent heart attack.
This trial compares placing a tiny mesh tube (stent) to open the narrowed kidney artery versus continuing blood pressure medicines alone. It is for people whose high blood pressure is hard to control even with multiple medications and who have a blockage in the kidney artery that can be treated.
This study compares different combinations of antiplatelet (blood-thinning for the stent) and cholesterol-lowering (statin) medicines after stent placement for a heart attack or unstable angina. The goal is to find the best way to prevent future heart problems and improve outcomes.
Hear when a new High blood pressure trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.